Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Determining the effect of single nucleotide polymorphisms in the type 1 fimbrial adhesin of Adherent-Invasive Escherichia coli on gut colonization, inflammation and innate immunity
EF 2010-11
Résumé
Crohn's Disease is a chronic inflammatory bowel disease characterized by recurrent inflammation of the small intestine and colon leading to severe abdominal pain and other bowel complications, which often require therapeutic surgical intervention with limited success. Although the causative agent of Crohn's Disease is unknown, current understanding suggests that pathogenic Escherichia coli bacteria which can reside within the gut and induce an inflammatory immune response may contribute to the development or progression of Crohn's Disease. In order to live within the gut, pathogenic E. coli must first adhere to the cells lining the small intestine and colon. Adherence requires the expression of filamentous surface structures termed type 1 pili which mediate adherence through the adhesin protein FimH. FimH has been shown to be important for virulence and capable of generating an inflammatory immune response. Within the genetic sequence of FimH, certain mutations have been identified that have been linked to inflammatory bowel disease, although their effect on the function of FimH is unknown. We propose to characterize these mutations in order to better understand how FimH contributes to the ability of pathogenic E. coli to reside within the gut. FimH represents an important therapeutic target as it is essential for virulence and development of inflammation in the gut.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
224324
Name
Grant Lauren
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Determining the effect of single nucleotide polymorphisms in the type 1 fimbrial adhesin of Adherent-Invasive Escherichia coli on gut colonization, inflammation and innate immunity
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adherent-Invasive Escherichia Coli; Ceabac10 Mouse Model; Crohn'S Disease; Fimh; Inflammatory Bowel Disease; Single Nucleotide Polymorphisms; Toll-Like Receptor 4
Abstract
Crohn's Disease is a chronic inflammatory bowel disease characterized by recurrent inflammation of the small intestine and colon leading to severe abdominal pain and other bowel complications, which often require therapeutic surgical intervention with limited success. Although the causative agent of Crohn's Disease is unknown, current understanding suggests that pathogenic Escherichia coli bacteria which can reside within the gut and induce an inflammatory immune response may contribute to the development or progression of Crohn's Disease. In order to live within the gut, pathogenic E. coli must first adhere to the cells lining the small intestine and colon. Adherence requires the expression of filamentous surface structures termed type 1 pili which mediate adherence through the adhesin protein FimH. FimH has been shown to be important for virulence and capable of generating an inflammatory immune response. Within the genetic sequence of FimH, certain mutations have been identified that have been linked to inflammatory bowel disease, although their effect on the function of FimH is unknown. We propose to characterize these mutations in order to better understand how FimH contributes to the ability of pathogenic E. coli to reside within the gut. FimH represents an important therapeutic target as it is essential for virulence and development of inflammation in the gut.
Competitiondate
201102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Grant, Lauren
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~